Hypercarbia during carbon dioxide pneumoperitoneum.

Area of Science:

• Anesthesiology
• Pulmonary Medicine
• Surgical Innovation

Background:

• Laparoscopic surgery using carbon dioxide (CO2) pneumoperitoneum can lead to CO2 retention and respiratory acidosis in patients with cardiopulmonary insufficiency.
• Pulmonary emphysema exacerbates CO2 retention during CO2 pneumoperitoneum, potentially leading to underestimation of hypercarbia by end-tidal CO2 monitoring.

Purpose of the Study:

• To evaluate the respiratory effects of CO2 and helium pneumoperitoneum in a canine model of induced pulmonary emphysema.
• To compare CO2 retention and respiratory acidosis between CO2 and helium pneumoperitoneum in healthy and emphysematous canine lungs.

Main Methods:

• A canine model of pulmonary emphysema was created using papain inhalation.
• Physiologic parameters, including end-tidal CO2 (ETCO2) and arterial carbon dioxide pressure (PaCO2), were monitored during baseline and pneumoperitoneum periods under mechanical ventilation.
• Hemodynamic and respiratory parameters were compared using analysis of variance.

Main Results:

• CO2 pneumoperitoneum consistently caused hypercarbia in all dogs, with significantly increased CO2 retention in the emphysematous state.
• An increased PaCO2-ETCO2 gradient indicated that ETCO2 monitoring may underestimate hypercarbia during CO2 pneumoperitoneum, especially in emphysematous lungs.
• Helium pneumoperitoneum did not induce hypercarbic or acidic changes compared to baseline, regardless of the pulmonary condition.

Conclusions:

• Helium pneumoperitoneum appears to be a safe alternative to CO2 pneumoperitoneum in patients susceptible to CO2 retention.
• This finding is particularly relevant for patients with compromised cardiopulmonary function or emphysema undergoing laparoscopic procedures.